Treatment of corneal ulcers in ocular surface inflammation

Session Details

Session Title: Cornea Medical

Session Date/Time: Tuesday 16/09/2014 | 14:00-16:00

Paper Time: 14:48

Venue: Capital Hall A

First Author: : S.Lazreg ALGERIA

Co Author(s): :    M. Benali Abdellah              

Abstract Details

Purpose:

To evaluate the efficacy of matrix therapy in the treatment of corneal ulcers

Setting:

7 cases of corneal ulcers treated with matrix therapy in Algeria

Methods:

5 cases of ocular surface inflammation with severe corneal ulcers resistant to conventional treatment , all treated with à new matrix therapy agent (cacicol 20%) 1 drop a day every other day for 4 weeks , with biomicroscopic records at D0 , D3, D7, D 15 and D30.

Results:

patients were aged between 18 to 66 years old, ocular surface inflammation was due to GVHD, severe Sjögren's Syndrome, Atopic keratoconjuctivitis, ocular pymphygoide and Stevens Johnson syndrome, all ulcers were chronic and rebels to different treatment ,at D7 we observed a decrease on VAs pain scale at D15 in all cases a total epitheliazitation of the ulcers ,

Conclusions:

CACICOL 20® is a new ophthalmic device, derived from RGTA based matrix therapy (large biopolymers engineered to replace heparan sulfates) , wich is a revolution in treatment of chronic ulcers, in our cases it has a double effect antalgic and regenerating .

Financial Interest:

NONE